Financial Gravity Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Financial Gravity Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14	Closed	-$636	–	1812
2023 Q2	$636	Buy	+14	New	+$239	﹤0.01%	945
2019 Q4	–	Sell	-117	Closed	-$1K	–	1738
2019 Q3	$1K	Hold	117	–	–	﹤0.01%	1137
2019 Q2	$1K	Hold	117	–	–	﹤0.01%	1157
2019 Q1	$0	Buy	+117	New	+$477	﹤0.01%	1578
2018 Q3	$1K	Sell	122 -7	-5%	-$41	﹤0.01%	1281
2018 Q2	$1K	Sell	129 -3	-2%	-$10	﹤0.01%	1303
2018 Q1	$0	Buy	+132	New	+$408	﹤0.01%	1522

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Financial Gravity Asset Management's CDMO Position: Q3 2023 in Review

Financial Gravity Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2023, closing a stake of 14 shares — an estimated $636 sold.

Financial Gravity Asset Management first reported a position in CDMO in Q1 2018 and held it in 7 quarters. The position peaked at $1K in Q3 2019. 170 funds tracked by Wall St. Rank hold CDMO as of Q3 2023.

Financial Gravity Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Financial Gravity Asset Management sold 14 Avid Bioservices, Inc. Common Stock shares in Q3 2023, an estimated $636.
Financial Gravity Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
Financial Gravity Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $1K in Q3 2019.
170 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2023.

Based on Financial Gravity Asset Management's 13F filing for Q3 2023, filed 16 Nov 2023.